Tumor-infiltrating CD4(+) T cells in patients with gastric cancer.
Tumor-infiltrating CD4(+) T cells in patients with gastric cancer.
复制标题
DOI:
10.1186/s12935-017-0489-4
复制
发表时间:
2017
影响因子:
5.8
通讯作者:
Gao Q
中科院分区:
文献类型:
--
作者:
Yuan L;Xu B;Yuan P;Zhou J;Qin P;Han L;Chen G;Wang Z;Run Z;Zhao P;Gao Q
T lymphocytes play an indispensably important role in clearing virus and tumor antigen. There is little knowledge about impacts of inhibitory molecules with cytokine on tumor-infiltrating CD4+ T-cells in the presence of gastric cancer (GC). This study investigated the distribution of tumor-infiltrating T-cells subset and the differentiation as well as inhibitory phenotype of T-cells from blood and tissues of GC patients. Patients with GC diagnosed on the basis of pre-operative staging and laparotomy findings were approached for enrollment between 2014 and 2015 at the Affiliated Cancer Hospital of Zhengzhou University, China. Phenotypic analysis based on isolation of tumor-infiltrating lymphocytes and intracellular IFN-γ staining assay is conducted. Statistical analysis is performed to show significance. The results showed that the percentage of CD4+ T-cells among CD3+ cells in tumors was significantly higher than that in the matched paraneoplastic tissue. CD4+ CD25high CD127low regulatory T-cells (Tregs), PD-1+, Tim-3+, and PD-1+ Tim-3+ cells were up-regulated on tumor infiltrating T-cells from patients with GC compared to their expressions on corresponding peripheral blood and peritumoral T-cells. Blockades of PD-1+ and Tim-3+ were effective in restoring tumor infiltrating T-cells’ production of interferon-gamma (IFN-γ). Combined PD-1+ and Tim-3+ inhibition had a synergistic effect on IFN-γ secretion by CD4+ T-cells. The results suggested that the composition, inhibitors, and location of the immune infiltrate should be considered when evaluating antitumor immunotherapy. A new insight into the mechanisms underlying T cell dysfunction is provided. The online version of this article (10.1186/s12935-017-0489-4) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
6.7
作者:
Fromentin R;Bakeman W;Lawani MB;Khoury G;Hartogensis W;DaFonseca S;Killian M;Epling L;Hoh R;Sinclair E;Hecht FM;Bacchetti P;Deeks SG;Lewin SR;Sékaly RP;Chomont N
通讯作者:
Chomont N
影响因子:
7.2
作者:
Carlson LM;De Geer A;Sveinbjørnsson B;Orrego A;Martinsson T;Kogner P;Levitskaya J
通讯作者:
Levitskaya J
DOI:
10.1158/1078-0432.ccr-15-1535
发表时间:
2017-01-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Kim JE;Patel MA;Mangraviti A;Kim ES;Theodros D;Velarde E;Liu A;Sankey EW;Tam A;Xu H;Mathios D;Jackson CM;Harris-Bookman S;Garzon-Muvdi T;Sheu M;Martin AM;Tyler BM;Tran PT;Ye X;Olivi A;Taube JM;Burger PC;Drake CG;Brem H;Pardoll DM;Lim M
通讯作者:
Lim M
影响因子:
--
作者:
Derks S;Liao X;Chiaravalli AM;Xu X;Camargo MC;Solcia E;Sessa F;Fleitas T;Freeman GJ;Rodig SJ;Rabkin CS;Bass AJ
通讯作者:
Bass AJ
影响因子:
3.9
作者:
Liu, Jun;Li, Hui;Hao, Xishan
通讯作者:
Hao, Xishan